Skip to content Skip to table of contents

This article is part of: MEB Annual Report 2016

2016: The year in overview

Photo de Jong Gortemaker Algra

The year in overviewBelow you find an overview of events during 2016.

January, February, March

7 January European referral of salbutamol Sandoz aërosol

7 January Kees van Nieuwkoop sworn in as new MEB member

13 January Shortage of Thyrax Duotab 0.025 mg (levothyroxine)

22 January Court ruling on usage patents and publication

8 February Adjustment of policy on usage patients and publication

9 March International cooperation between medicines regulatory authorities in fight against Zika virus

31 March Workshop on ‘patient data in registers’

April, May, June

1 April PSUR repository in ‘switch-on’ phase

12 April MEB presents folder on biological medicines

29 April Amendment of letters and decisions by the Veterinary Medicinal Products Unit

4 May Marcel Bouvy and Gabe Sonke sworn in as new MEB members today

9 May Policy rule on classification of veterinary medicinal products published

19 May MEB launches project: clear patient information leaflet for OTC medicines

31 May Start of Young MEB

8 June MEB Day 2016: 'Science and Europe'

July, August, September

12 July MEB on Medicijnjournaal about drug rediscovery

18 July Guidance on the Substantiation of Claims made on Animal Nutrition updated

22 July Amended policy for national implementation of additional risk minimisation measures

25 August Henk-Jan Guchelaar sworn in as new MEB member

28 September MEB co-organiser of TOPRA

30 September Shelf life after opening to be included on packaging of OTC medicinal products

October, November, December

20 October MEB recommendation: keep patient in mind when switching generic medicines

7 November Adverse events week calls for attention for reporting adverse events of medicinal products

10 November Kijksluiter useful addition for proper use of medicines

23 November Additional instructions on shelf life after opening of OTC medicinal products

29 November MEB joins European partnership on research into Alzheimer’s disease

1 December Bert Leufkens announces departure as Chairman of the MEB

15 December Tougher requirements on the packaging of medicinal products to prevent falsification

Go to Table of Contents